Clinical Trial Update: CHO(E)P-14 Followed by Alemtuzumab Consolidation in Peripheral T Cell Lymphoma [Phase 2]

View source ↗

Summary

This clinical trial update notes the completion of a Phase 2 study evaluating CHO(E)P-14 chemotherapy followed by alemtuzumab consolidation in Peripheral T-cell…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral T-cell Lymphoma

Drugs mentioned

• Alemtuzumab (Alemtuzumab)

Snippet

Sponsor: University of Göttingen | Conditions: Peripheral T-Cell Lymphoma | Phase 2 | Status: COMPLETED